title: Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.
abstract: BACKGROUND
  Sepsis, severe sepsis and septic shock are common conditions with high mortality. Their early diagnosis in the Emergency Department (ED) is one of the keys to improving survival. Procalcitonin (PCT) has been used as a biomarker in septic patients but has limited specificity and can be elevated in other scenarios of systemic inflammatory response syndrome (SIRS). Soluble CD14 (sCD14) or presepsin is the free fragment of a glycoprotein expressed on monocytes and macrophages. Preliminary reports suggest that levels of presepsin are significantly higher in septic patients than in healthy individuals. The aim of this study is to investigate the diagnostic and prognostic value of presepsin compared to PCT in people presenting at the ED with SIRS and suspected sepsis or septic shock.
  
  
  METHODS
  This study was conducted in two major hospitals in Turin, Italy. One hundred six patients presenting to the EDs with suspected sepsis or septic shock were included, and another eighty-three patients affected by SIRS, but with no clinical evidence of infection, were recruited as controls. Blood samples were collected at first medical evaluation and for some patients after 24 and 72 h. The samples were analyzed using the PATHFAST Presepsin assay for sCD14, and commercial kits were used for other determinations (for example, PCT). Definitive diagnosis and survival rates were obtained afterward by analysis of digital medical records.
  
  
  RESULTS
  Elevated concentrations of presepsin at presentation were observed in septic patients compared to control patients. The same trend was observed for mean values of PCT. Higher values of presepsin were observed in septic patients at presentation (time 0). The diagnostic accuracy of PCT was generally higher, and areas under the curve (AUCs) were 0.875 for PCT and 0.701 for presepsin. Mean presepsin values were significantly higher in nonsurvivor septic patients (60-day mortality) than in survivors. No significant correlation was noted between PCT and survival.
  
  
  CONCLUSIONS
  In our experience, presepsin was useful in the early diagnosis of infection in a complex population of patients with SIRS, sepsis, severe sepsis and septic shock who presented to the ED. Presepsin showed a significant prognostic value, and initial values were significantly correlated with in-hospital mortality of patients affected by sepsis, severe sepsis or septic shock.
authors.forename: Marco
authors.initials: M
authors.lastname: Ulla
authors.forename: Elisa
authors.initials: E
authors.lastname: Pizzolato
authors.forename: Manuela
authors.initials: M
authors.lastname: Lucchiari
authors.forename: Maria
authors.initials: M
authors.lastname: Loiacono
authors.forename: Flavia
authors.initials: F
authors.lastname: Soardo
authors.forename: Daniela
authors.initials: D
authors.lastname: Forno
authors.forename: Fulvio
authors.initials: F
authors.lastname: Morello
authors.forename: Enrico
authors.initials: E
authors.lastname: Lupia
authors.forename: Corrado
authors.initials: C
authors.lastname: Moiraghi
authors.forename: Giulio
authors.initials: G
authors.lastname: Mengozzi
authors.forename: Stefania
authors.initials: S
authors.lastname: Battista
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D019468:Disease Management; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D018950:Lipopolysaccharide Receptors / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000097:blood*; D011379:Prognosis; D011446:Prospective Studies; D018805:Sepsis / Q000097:blood* / Q000175:diagnosis* / Q000628:therapy; D055815:Young Adult
chemical_list: D015415:Biomarkers; D018950:Lipopolysaccharide Receptors; D010446:Peptide Fragments; C000594167:presepsin protein, human
references.citation: Crit Care Med. 2001 Jul;29(7):1303-10
references.pmid: 11445675
references.citation: J Matern Fetal Neonatal Med. 2012 Oct;25(Suppl 5):51-3
references.pmid: 23025769
references.citation: Crit Care Med. 2011 Jul;39(7):1792-9
references.pmid: 21358400
references.citation: Crit Care Med. 2013 Feb;41(2):580-637
references.pmid: 23353941
references.citation: J Infect Chemother. 2012 Dec;18(6):891-7
references.pmid: 22692596
references.citation: N Engl J Med. 2003 Apr 17;348(16):1546-54
references.pmid: 12700374
references.citation: Crit Care Med. 2003 Mar;31(3):946-55
references.pmid: 12627010
references.citation: Lancet Infect Dis. 2007 Mar;7(3):210-7
references.pmid: 17317602
references.citation: Eur J Emerg Med. 2008 Feb;15(1):26-33
references.pmid: 18180663
references.citation: Crit Care Med. 2007 May;35(5):1244-50
references.pmid: 17414736
references.citation: N Engl J Med. 2001 Nov 8;345(19):1368-77
references.pmid: 11794169
references.citation: Anaesthesia. 2007 May;62(5):466-73
references.pmid: 17448058
references.citation: J Infect Chemother. 2011 Dec;17(6):764-9
references.pmid: 21560033
references.citation: Crit Care Clin. 2008 Jul;24(3 Suppl):S1-47
references.pmid: 18634996
references.citation: J Immunol. 1995 Jul 1;155(1):316-24
references.pmid: 7541418
references.citation: Int J Legal Med. 2013 Jul;127(4):799-808
references.pmid: 23263410
references.citation: Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 Jun;22(6):331-4
references.pmid: 20594464
references.citation: Chest. 1992 Jun;101(6):1644-55
references.pmid: 1303622
references.citation: J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:12-4
references.pmid: 21740312
references.citation: Clin Chem Lab Med. 2011 May;49(5):937-9
references.pmid: 21345045
references.citation: Crit Care. 2004 Aug;8(4):222-6
references.pmid: 15312201
references.citation: Crit Care Med. 2008 Jan;36(1):296-327
references.pmid: 18158437
references.citation: Intensive Care Med. 1996 Jul;22(7):707-10
references.pmid: 8844239
references.citation: J Infect Chemother. 2005 Oct;11(5):234-8
references.pmid: 16258819